Does Linagliptin And Metformin Hydrochloride Interact with Topiramate?
Linagliptin And Metformin Hydrochloride and Topiramate have a major drug interaction according to U.S. FDA drug labeling data. Carbonic anhydrase inhibitors like topiramate decrease serum bicarbonate and induce metabolic acidosis, increasing risk of lactic acidosis when combined with linagliptin and metformin. The mechanism involves decreases serum bicarbonate and induces non-anion gap, hyperchloremic metabolic acidosis. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Linagliptin And Metformin Hydrochloride Class
- Dipeptidyl Peptidase 4 Inhibitor
- Topiramate Class
- Cytochrome P450 3A4 Inducers
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Linagliptin And Metformin Hydrochloride and Topiramate occurs because decreases serum bicarbonate and induces non-anion gap, hyperchloremic metabolic acidosis. Clinically, this means carbonic anhydrase inhibitors like topiramate decrease serum bicarbonate and induce metabolic acidosis, increasing risk of lactic acidosis when combined with linagliptin and metformin. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Linagliptin And Metformin Hydrochloride and your doctor is considering prescribing Topiramate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider